No Data
Nomura Adjusts Aier Eye Hospital Group's Price Target to 15.46 Yuan From 15.40 Yuan, Keeps at Neutral
What Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) P/E Is Not Telling You
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
Aier Eye Hospital Group (300015.SZ): AierGPT, a large vertical model, focuses on the field of ophthalmology.
On February 11, Gelonghui reported that Aier Eye Hospital Group (300015.SZ) stated on the investor interaction platform that the AierGPT ophthalmic vertical model focuses on the ophthalmology field, covering multiple downstream tasks such as optometry, refraction, cataracts, and fundus, providing training, guidance, auxiliary diagnosis, and popular science services. This model utilizes Aier Eye Hospital Group's proprietary database, ophthalmic book materials, as well as knowledge enhancement through collaboration with open-source medical Q&A datasets, aiming to improve the answering capability and service quality for ophthalmology-related issues, and to promote the digitalization of the group's ophthalmic service model and the intelligentization of hospitals.
UOB Kay Hian Downgrades Aier Eye Hospital Group to Hold From Buy; Price Target Is 13.80 Yuan
Aier Eye Hospital Group (SZSE:300015) Shareholders Have Endured a 36% Loss From Investing in the Stock Three Years Ago
102884128 : getting disappointed with this counter. every day drop.